Blue Earth Diagnostics Announces Key Results from Phase 3 SP

Totality of results support Company proceeding with New Drug Application to U.S. Food and Drug Administration

Related Keywords

Munich , Bayern , Germany , United States , David Gauden , Scintomics Gmb , Davidm Schuster , Technical University Of Munich , Emory University School Of Medicine , Drug Administration , Winship Cancer Institute Of Emory University , Blue Earth Diagnostics , Cancers Symposium , Prostate Specific Membrane Antigen Targeted , Correct Detection Rate , Positive Predictive Value , Winship Cancer Institute , Emory University , Emory University School , Coordinating Investigator , Chief Scientific Officer , Blue Earth , New Drug Application , Radiohybrid Prostate Specific Membrane Antigen , Technical University , Scintomics Gmbh , Earth Diagnostics ,